| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 05/29/2008 | US20080125434 E. g., 6-(4-benzooxazol-2-yl-piperazin-1-yl)pyridazine-3-carboxylic acid (2-cyclopropylethyl)amide; diseases such as related to dyslipidemia and metabolism disorders of lipid; especially diseases related to elevated lipid levels, cardiovascular disease, antidiabetic agents; obesity; anticholesterol agent |
| 05/29/2008 | US20080125432 E.g., 2-(4-fluoro-phenylamino)-4-methyl-thiazole-5-carboxylic acid ((S)-1-naphthalen-2-yl-ethyl)-amide; blockingion channels of the Ky1, the Ky3, and the Ky1.5 subfamilies; nervous system disorders; cardiotonic agents; antiepileptic agents; anxiolytic agents; multiple sclerosis; Alzheimer's diseasse |
| 05/29/2008 | US20080125427 Novel Inhibitors of Rho-Kinases |
| 05/29/2008 | US20080125423 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
| 05/29/2008 | US20080125418 Benzimidazole derivatives and their use as kdr kinase protein inhibitors |
| 05/29/2008 | US20080125416 Sigma Receptor Inhibitors |
| 05/29/2008 | US20080125376 Viricide against hepatitis virus; pyrrole derivatives as, for example, 3-acetyl-4,5-dimethyl-2-pyrrole carboxylic acid |
| 05/29/2008 | US20080124572 A carbazole skeleton to which a diarylamino group bonds via a bonding group as a hole transporting material or a hole injecting material has an enhanced efficiency of light emission and is highly practical; enhances yield in device, improves lifetime |
| 05/29/2008 | CA2670468A1 Melatonin derivatives and their use as antioxidants |
| 05/29/2008 | CA2670417A1 Tricarbonyl complexes with tridentate chelators for myocardium imaging |
| 05/29/2008 | CA2670207A1 Process for preparing a crystalline form of candesartan cilexetil |
| 05/29/2008 | CA2668661A1 Substituted pyrazole and triazole compounds as ksp inhibitors |
| 05/29/2008 | CA2668578A1 Pyridazin-4-ylmethyl-sulfonamides used as fungicides |
| 05/29/2008 | CA2668567A1 Pyrimidylmethyl-sulfonamide compounds useful as fungicides and against arthropods |
| 05/29/2008 | CA2650227A1 Substituted pyrazolopyrimidines |
| 05/28/2008 | EP1924578A2 6-N-LINKED HETEROCYCLE-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS |
| 05/28/2008 | EP1924573A1 B-raf inhibitors |
| 05/28/2008 | EP1924568A1 Quinazoline derivatives useful in cancer treatment |
| 05/28/2008 | EP1924567A2 Process for the preparation of pyrimidinedione derivatives |
| 05/28/2008 | EP1924566A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 05/28/2008 | EP1924564A1 Diaminopyrimidines as p2x3 and p2x2/3 modulators |
| 05/28/2008 | EP1924561A2 6-arylalkylamino- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 05/28/2008 | EP1924560A1 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists |
| 05/28/2008 | EP1701940B1 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
| 05/28/2008 | EP1485354B1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 05/28/2008 | EP1218360B1 Triazine kinase inhibitors |
| 05/28/2008 | CN101189228A Bicyclic [3.1.0] heteroaryl amides as type I glycine transport inhibitors |
| 05/28/2008 | CN101189227A New derivatives of pyrrolyltriazine together with methods for obtaining them and their use as protecting agents against uv radiation |
| 05/28/2008 | CN101189223A 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 05/28/2008 | CN101189214A Substituted 4,5-dihydro-1,2,4-triazin-6-ones, 1,2,4-triazin-6-ones, and their use as fungicides |
| 05/28/2008 | CN100390212C Water-dispersible, cationic polymers, a method of making same and items using same |
| 05/28/2008 | CN100390165C Medicinal composition containing alkyl acyl ramosqiong and its application |
| 05/28/2008 | CN100390156C Novel antibacterial compounds, process for their preparation and pharmaceutical compositions containing them |
| 05/28/2008 | CN100390155C Quinoline and quinoxaline compounds |
| 05/28/2008 | CN100390154C Quinoline and quinoxaline compounds as PDGF-receptor and/or LCK tyrosine kinase inhibitors |
| 05/27/2008 | US7378529 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 05/27/2008 | US7378439 Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride |
| 05/27/2008 | US7378438 Asthma; side effect reduction; converting SH groups to SNO groups of N-benzylphthalimide usingHCl and NaNO2; epoxide or thioepoxid of N-benzylphthalimide; amination; 5-{2-[(1-Yloxyl-2,2,5,5-tetramethyl-pyrrolidin-3-ylmethyl)-amino]-1-S-nitroso-ethyl}-1,1,3,3-tetramethylisoindolin-2-yloxyl, hydrochloride |
| 05/27/2008 | US7378433 N-[4-(heteroarylmethyl)phenyl]-heteroarylamines |
| 05/27/2008 | US7378431 Amide derivatives as NMDA receptor antagonists |
| 05/27/2008 | US7378422 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 05/27/2008 | US7378420 4-[(2,4-dichloro-phenyl)-phenyl-methyl]-piperazine-1-carboxylic acid benzhydryl-amide; conjugated to polyethylene glycol; analgesic, antidiabetic and anticarcinogenic agent, antidepressant, anxiolytic agent |
| 05/27/2008 | US7378161 Organometallic complexes and organic electroluminescence device using the same |
| 05/22/2008 | WO2008061109A2 Indazole derivatives useful as melanin concentrating receptor ligands |
| 05/22/2008 | WO2008060998A1 Indole sulfonamides as sfrp-1 modulators |
| 05/22/2008 | WO2008060771A2 Pyrazole compounds |
| 05/22/2008 | WO2008060190A2 Ligands of 5-ht6 receptors, a pharmaceutical composition, method for the production and use thereof |
| 05/22/2008 | WO2008059259A2 Anticancer compounds with a benzo ( 1, 2, 4 ) triazin-3yl-amine core |
| 05/22/2008 | WO2008059207A1 Cannabinoid receptor modulators |
| 05/22/2008 | WO2008058867A2 Substituted 4-imidazoles |
| 05/22/2008 | WO2008058341A1 Inhibitors of kinase activity |
| 05/22/2008 | WO2008042282A3 Imidazole-4, 5-dicarboxamide derivatives as jak-2 modulators |
| 05/22/2008 | WO2008011392A3 Proline urea ccr1 antagonists for the treatment of autoimmune diseases or inflammation |
| 05/22/2008 | WO2008001195A3 Novel processes for the preparation of dpp iv inhibitors |
| 05/22/2008 | WO2007138431A3 Azabicyclic ether histamine-3 antagonists |
| 05/22/2008 | WO2007127725A3 Diazeniumdiolated non-steroidal anti-inflammatory drugs, compositions thereof, and related methods |
| 05/22/2008 | US20080119659 Fluorinated bis (phthalic anhydride) and method for producing the same |
| 05/22/2008 | US20080119657 precursors for angiotensin II antagonists; deprotecting reactive tetrazole nitrogen with an anhydrous or concentrated aqueous solution of a hydrohalic acid; (2-butyl-5-chloro-3-{2'-[2-(1-methyl-1-phenyl-ethyl)-2H-tetrazol-5-yl]-biphenyl-4-ylmethyl}-3H-imidazol-4-yl)-methanol |
| 05/22/2008 | US20080119648 Histone deacetylase inhibitors |
| 05/22/2008 | US20080119643 Based on diaminobenzanilides or, more specifically (aminobenzoylamino),(sulfo-),(methoxy)anilines; stable aqueous solutions;nonbleeding/colorfastness; excellent degrees of exhaustion with high color strength; dyeing natural or synthetic materials, particularly, paper; neutral or greenish-yellow hues |
| 05/22/2008 | US20080119535 Aminomethyl-4-imidazoles |
| 05/22/2008 | US20080119524 Treating conditions related to Ras or Ras-like protein prenylation such as cancer, restenosis, psoriasis, endometriosis, atherosclerosis, ischemia, myocardial ischemic disorders; amide-functional pyrazole compounds containing 2,2-dimethylcyclobutan-1,3-ylene moiety |
| 05/22/2008 | US20080119521 Butyrlcholinesterase Selective Inhibitors |
| 05/22/2008 | US20080119520 Disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight; benzoxazole, benzimidazole, and indole compounds substituted with pyrrole, azepane, piperidine or azetidine e.g. 4-{2-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-benzooxazol-5-yl}-benzonitrile |
| 05/22/2008 | US20080119518 Indole-6-carboxamides; for example 1-[1-[2-(2-methoxy-4-methoxymethylphenyl)ethyl]piperidin-4-yl]-1H-indole-6-carboxamide; treating frequent urination and incontinence; 5-HT1A receptor antagonists |
| 05/22/2008 | US20080119492 anticarcinogenic agent; composition with guanine G-quadruplex spacer structure that fixing themselves to the O-quadruplex structure formed by the telomeres, thus inhibiting telomerase activity; regulate cell proliferation, anticarcinogenic agent; synergistic with other chemotherapeutic agents |
| 05/22/2008 | US20080119490 Viral Polymerase Inhibitors |
| 05/22/2008 | US20080119485 Novel Benzofurans and Indols |
| 05/22/2008 | US20080119477 N-Biaryl and N-Arylheteroaryl Piperazine Derivatives as Modulators of the 5Ht2c Receptor Useful For the Treatment of Disorders Related Thereto |
| 05/22/2008 | US20080119470 8-hydroxy-3H-quinazolin-4-(thi)one derivatives; ability to enter CNS, sequester transition metals Cu, Zn and Fe from various amiloid beta entities, reducing their toxicity; neurodegenerative disorders; Alzheimer's, Parkinson's, Cruetzfeldt-Jacob diseases, amyotrophic lateral sclerosis, cataract |
| 05/22/2008 | US20080119468 Phthalazine, aza-and diaza-phthalazine compounds and methods of use |
| 05/22/2008 | US20080119465 Novel Indoline Compounds |
| 05/22/2008 | US20080119464 N-(4-piperidin-1-yl-phenyl)-2-[5-(thiaxolidine-3-carbonyl)-pyrrolidin-3-ylidene]-acetamide;antidiabetic agents; hyperglycemia, syndrome X, hyperinsulinemia, obesity, atherosclerosis |
| 05/22/2008 | US20080119460 {2-Amino-4-[(4-(4-chlorophenyl)piperidin-1-yl)methyl]thiophen-3-yl}(4-chlorophenyl)methanone; analgesic, antidepressant; cardiac disease or disorder, neurological disease or injury, sleep disorder, epilepsy, neuropathic pain, angina |
| 05/22/2008 | US20080119458 N-substituted-azacyclylamines as histamine-3 antagonists |
| 05/22/2008 | US20080119457 2-Bromo-4-(1,5,5-trimethyl-7-oxo-4,5,6,7-tetrahydro-1H-indazol-3-yl)-benzonitrile; heat-shock protein 90 inhibitors; anticarcinogenic, antiinflammatory agent, angiogenesis inhibitor, fungicide; arthritis, ischemia, solid tumors, leukemia |
| 05/22/2008 | US20080119456 [2-benzhydryl-4-(4-chlorophenyl)-thiazol-5-yl]-acetic acid; Chemoattractant Receptor-homologous molecule expressed on T Helper cells type 2 ligand; antiallergen and antiinflammatory agent; asthma, rhinitis, allergic airway syndrome, allergic rhinobronchitis; Alzheimer's disease, rheumatoid arthritis |
| 05/22/2008 | US20080119451 N-(2-aminophenyl)-4-(3-methylpyridin-2-yl)benzamide; histone deacetylase (HDAC) and angiogenesis inhibitor; antiproliferative agent; solid tumor cancers, lymphomas, myelomas, melanomas; antiinflammatory agent; arthritis, psoriasis, multiple sclerosis, asthma |
| 05/22/2008 | US20080119442 as hypoxia-selective drugs and radiosensitizers for cancer therapy; nitroreductase inhibitor; 1-(Chloromethyl)-5,6-dinitro-3-(5,6,7-trimethoxyindol-2-carbonyl)-1,2-dihydro-3H-benzo[e]indole; halogenation of naphthalene derivative followed by hydration and cyclization |
| 05/22/2008 | CA2701959A1 Inhibitors of kinase activity |
| 05/22/2008 | CA2669112A1 Substituted 4-imidazoles |
| 05/22/2008 | CA2669080A1 Cannabinoid receptor modulators |
| 05/21/2008 | EP1923390A1 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 05/21/2008 | EP1923387A1 Acylguanidine derivative or salt thereof |
| 05/21/2008 | EP1923386A2 Carbamate caspase inhibitors and uses thereof |
| 05/21/2008 | EP1922313A1 Pyrazine derivatives useful as adenosine receptor antagonists |
| 05/21/2008 | EP1434773B1 Heteroaryl substituted tetrazole modulators of metabotropic glutamate receptor-5 |
| 05/21/2008 | EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 05/21/2008 | EP1261586B1 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv, processes for their preparation, and their use |
| 05/21/2008 | DE102007053198A1 Photoinitiatoren für strahlungshärtbare Beschichtungsmassen Photoinitiators for radiation-curable coating compositions |
| 05/21/2008 | CN101184751A Quinazolines and their use as AURORA kinase inhibitors |
| 05/21/2008 | CN101184734A Compositions and methods of treating cell proliferation disorders |
| 05/21/2008 | CN101184731A New sulfonylindoline compounds |
| 05/21/2008 | CN101184728A Peptide deformylase (PDF) inhibitors 4 |
| 05/21/2008 | CN101182320A Compound capable of inhibiting growth of bacillus tubercle and uses thereof |
| 05/21/2008 | CN101182308A Imidazole chiral ionic liquids containing double function groups as well as preparation method and uses thereof |
| 05/21/2008 | CN100389113C Nitrogenous heterocyclic compound and medicine containing the same |
| 05/21/2008 | CN100389109C Non-nucleoside reverse transcriptase inhibitors |
| 05/20/2008 | US7375234 Copper-catalysed ligation of azides and acetylenes |
| 05/20/2008 | US7375232 Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests |